Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ACTRN12626000756325) titled 'SCY-770 Multiple Ascending Dose Study in Healthy Participants (Cohorts 2-3)' on June 25.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Primary Sponsor: SCYNEXIS, Inc.
Condition:
Non-Alcoholic Fatty Liver Disease [NAFLD]
Non-Alcoholic Fatty Liver Disease [NAFLD]
Metabolic and Endocrine - Metabolic disorders
Intervention:
SCY770 will be provided as tablets for oral administration with 240ml of room temperature water and the same will be matched for Placebo
This study includes three parts (cohorts) and is conducted in hea...